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We are presenting the first issue of a new official journal of the 
Polish Society of Nuclear Medicine, which was formed by joining 
two periodicals: “Problemy Medycyny Nuklearnej” (“Problems in 
Nuclear Medicine”) and “Nuclear Medicine Review. East and 
Central Europe”. On 23 February 2011 an agreement in the said 
matter was signed between PTMN (Polish Society of Nuclear 
Medicine) and Via Medica publishing house — the owner of 
Nuclear Medicine Review.
Consequently, we have managed to combine the tradition 
of the first magazine, representing the Polish Society of Nuclear 
Medicine, published since 1987 and the modernity of the English 
periodical published since 1996, which has also become a sci-
entific forum for colleagues from the Central and Eastern Europe.
Nuclear Medicine Review will be published in January and June 
every year. With me, the editing team comprises: Mirosław Dziuk 
MD, PhD, ass. Prof. and Jolanta Kunikowska, MD, PhD as chief edi-
tor deputies, and Anna Budzyńska MSc Eng who runs the editorial 
office. The prestige of the periodical will depend on your activity. 
Therefore, I would be grateful to receive numerous interesting 
works from you all. I hope that in the immediate future “Nuclear 
Medicine Review” will achieve a good impact factor. 
Finally, I would like to express my appreciation to Professor 
Julian Liniecki and Professor Piotr Lass for establishing “Nuclear 
Medicine Review. East and Central Europe”, a unique journal 
which, on the “old continent”, united society members connected 
with nuclear medicine many years before European countries en-
tered into official political treaties. In hope for the fruitful cooperation 
of the whole society I would like to ensure on behalf of the editing 
team that we will do everything in our power to make “Nuclear 
Medicine Review” a worthy successor to its predecessors.
The main focus of the current issue of Nuclear Medicine Review 
is nuclear medicine in endocrinology. There are three interesting 
original articles from renowned nuclear medicine centres in Poland. 
 Dear Sirs and Madams,
The efficacy of hyperthyroidism treatment with I-131 is effective, 
but there is still some room for improvement. This may be the 
common conclusion from the first two papers. The first experi-
ences of PET-CT peptide imaging in patients with neuroendocrine 
tumours are presented in an article from Warsaw.  In addition to 
the original works there two review papers that can be useful for 
all nuclear medicine practitioners.   
There are two interesting case reports from Wroclaw and 
Olomouc nuclear medicine centres.  It is always good to see 
interesting patients and to remember the advantages and limita-
tions of imaging modalities. 
In the Past Events section of the journal you will find coverage 
from the very important meeting during which Honorary Member-
ship of the Polish Society of Nuclear Medicine was awarded to 
distinguished professors of Nuclear Medicine. The session was fol-
lowed by a symposium on PET-MR — an emerging hybrid modality. 
We encourage other societies to submit similar information about 
such events to the Editorial Office since we believe this may be 
interesting for our readers. 
I hope that the article about the first European Accreditation 
awarded to the Polish Nuclear Medicine Centre will persuade other 
centres to share their achievements with the wider community. In 
general the editors are very keen to collect and publish information 
about all of the nuclear medicine centres in our region of Europe 
in order to promote the exchange of knowledge and support 
international cooperation. 
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